BENITIONSClinical Trial Intelligence

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

第3相 完了 NCT05794555

対象疾患Cirrhosis, Liver, Portal Hypertension
第3相
スポンサーUniversity of Michigan
ステータス完了
参加者数233 名
介入(薬剤)Enhanced Usual Care, Lactulose, Investigator recommended exercise, TeleTai-Chi (virtual)
開始日2023年6月13日
完了日2025年3月7日
結果公開日2026年7月31日

概要

This multicenter trial is being conducted to determine if sequential lactulose and Tele (virtual) Tai-Chi reduces the rate of injurious fall, non-injurious falls, incident overt Hepatic Encephalopathy (HE), and death or liver transplant over 24 weeks. Participants that are enrolled will be randomized to stage one of this project for approximately 12 weeks. After completing stage one, participants will be re-randomized to stage 2 of the project that will last approximately 12 more weeks. The study hypothesizes that sequential lactulose/TeleTai-Chi will reduce falls, incident overt HE, death and physical frailty and will improve cognitive function, and Health Related Quality of Life (HRQOL) over 24 weeks compared to other treatment combinations. As detailed below, an observational component that enrolls caregivers of the trial participants is being conducted. Upon completion, Participants listed in the record here only include trial participants; and the observational component was moved to a new registration for clarity, NCT07140120.

Number of Participants Experiencing a Hierarchical Composite of Events Over 24 Weeks: Injurious Falls, Non-injurious Falls, Incident Hepatic Encephalopathy, Liver Transplant, and Death/Transplant

Baseline to 24 weeks · Participants

Treatment (Lactulose) Plus Enhanced Usual Care Then TeleTai-Chi Exercise Classes11 Participants
Treatment (Lactulose) Plus Enhanced Usual Care Then Recommended Exercise10 Participants
Enhanced Usual Care Group Followed by Tele-Tai Chi Exercise Classes14 Participants
Enhanced Usual Care Group Followed by Investigator Recommended Exercise29 Participants
p-value0.003

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。